COVID-19- and SARS-induced ARDS
AyuVis research is developing a new class of drugs to treat complicated respiratory infections such as BPD and PAP with promising preclinical data. Both of these indications are associated with ARDS, which can be induced by the Corona virus.
AyuVis research is developing a new class of drugs to treat complicated respiratory infections such as BPD and PAP with promising preclinical data. Both of these indications are associated with ARDS, which can be induced by the Corona virus.
Location: United States, Texas, Fort Worth